BIORESTORATIVE THERAPIES, INC. (BRTX) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
36/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinBRTX / S&P 38.18% / 15.20% |
LoseBRTX / S&P BRTX unavailable / 15.00% |
LoseBRTX / S&P BRTX unavailable / 50.40% |
| 2026-Q10/3 |
LoseBRTX / S&P -76.84% / -4.33% |
LoseBRTX / S&P -8.47% / 11.30% |
LoseBRTX / S&P -27.21% / 27.70% |
| 2025-Q41/3 |
LoseBRTX / S&P -18.97% / 2.65% |
LoseBRTX / S&P -10.30% / 9.00% |
WinBRTX / S&P 37.07% / 13.40% |
| 2025-Q30/3 |
LoseBRTX / S&P -12.94% / 8.12% |
LoseBRTX / S&P 1.70% / 4.61% |
LoseBRTX / S&P 2.80% / 13.45% |
| 2025-Q22/3 |
LoseBRTX / S&P -6.43% / 10.94% |
WinBRTX / S&P 247.62% / 4.83% |
WinBRTX / S&P 39.56% / 10.63% |
| 2025-Q12/3 |
WinBRTX / S&P 24.48% / -4.27% |
WinBRTX / S&P 161.54% / 4.98% |
LoseBRTX / S&P -21.81% / 10.57% |
| 2024-Q41/3 |
LoseBRTX / S&P -17.82% / 2.41% |
WinBRTX / S&P 175.03% / 5.25% |
LoseBRTX / S&P -66.67% / 6.15% |
| 2024-Q31/3 |
LoseBRTX / S&P -14.29% / 5.89% |
WinBRTX / S&P 189.55% / 5.89% |
LoseBRTX / S&P -65.87% / 6.11% |
| 2024-Q22/3 |
WinBRTX / S&P 47.10% / 4.28% |
WinBRTX / S&P 35.49% / 5.38% |
LoseBRTX / S&P -84.47% / 5.12% |
| 2024-Q11/3 |
LoseBRTX / S&P -20.69% / 10.56% |
WinBRTX / S&P 10.66% / 5.71% |
LoseBRTX / S&P -66.84% / 5.59% |
| 2023-Q41/3 |
LoseBRTX / S&P -2.80% / 11.69% |
WinBRTX / S&P 21.70% / 6.81% |
LoseBRTX / S&P BRTX unavailable / 7.78% |
| 2023-Q30/3 |
LoseBRTX / S&P -59.41% / -3.27% |
LoseBRTX / S&P 7.51% / 7.52% |
LoseBRTX / S&P BRTX unavailable / -5.03% |
| 2023-Q22/3 |
WinBRTX / S&P 29.71% / 8.74% |
WinBRTX / S&P 28.37% / 9.50% |
LoseBRTX / S&P BRTX unavailable / -8.57% |
| 2023-Q12/3 |
WinBRTX / S&P 23.64% / 7.50% |
WinBRTX / S&P 207.05% / 10.77% |
LoseBRTX / S&P BRTX unavailable / -15.69% |
| 2022-Q41/3 |
LoseBRTX / S&P -14.86% / 7.56% |
WinBRTX / S&P 160.43% / 11.88% |
LoseBRTX / S&P BRTX unavailable / -17.99% |
| 2022-Q32/3 |
WinBRTX / S&P 9.49% / -4.88% |
WinBRTX / S&P 108.79% / 13.47% |
LoseBRTX / S&P BRTX unavailable / -1.41% |
| 2022-Q21/3 |
LoseBRTX / S&P -43.59% / -16.10% |
WinBRTX / S&P 54.00% / 13.71% |
LoseBRTX / S&P BRTX unavailable / 11.04% |
| 2022-Q11/3 |
WinBRTX / S&P 20.51% / -4.60% |
LoseBRTX / S&P -36.23% / 15.97% |
LoseBRTX / S&P BRTX unavailable / 42.23% |
| 2021-Q40/3 |
LoseBRTX / S&P -69.86% / 11.03% |
LoseBRTX / S&P -40.26% / 15.00% |
LoseBRTX / S&P BRTX unavailable / 96.40% |
| 2021-Q30/3 |
LoseBRTX / S&P -40.00% / 0.58% |
LoseBRTX / S&P -36.96% / 10.77% |
LoseBRTX / S&P BRTX unavailable / 69.42% |
| 2021-Q20/3 |
LoseBRTX / S&P -50.00% / 8.55% |
LoseBRTX / S&P -43.48% / 6.58% |
LoseBRTX / S&P BRTX unavailable / 51.81% |
| 2021-Q11/3 |
WinBRTX / S&P 73.91% / 6.17% |
LoseBRTX / S&P -45.67% / -1.06% |
LoseBRTX / S&P BRTX unavailable / 7.39% |
| 2020-Q40/3 |
LoseBRTX / S&P -54.90% / 12.15% |
LoseBRTX / S&P -40.77% / -3.72% |
LoseBRTX / S&P BRTX unavailable / -33.42% |
| 2020-Q31/3 |
WinBRTX / S&P 15200.00% / 8.93% |
LoseBRTX / S&P -27.56% / -2.04% |
LoseBRTX / S&P BRTX unavailable / -27.10% |
| 2020-Q21/3 |
LoseBRTX / S&P 0.00% / 20.54% |
WinBRTX / S&P 0.00% / -0.46% |
LoseBRTX / S&P BRTX unavailable / -27.11% |
| 2020-Q11/3 |
LoseBRTX / S&P -98.00% / -19.60% |
WinBRTX / S&P 4.96% / 3.47% |
LoseBRTX / S&P BRTX unavailable / -14.75% |
| 2019-Q41/3 |
LoseBRTX / S&P -97.73% / 9.07% |
WinBRTX / S&P 17.12% / 5.36% |
LoseBRTX / S&P BRTX unavailable / 2.99% |
| 2019-Q31/3 |
LoseBRTX / S&P -39.41% / 1.70% |
WinBRTX / S&P 5.83% / 5.02% |
LoseBRTX / S&P BRTX unavailable / 0.21% |
| 2019-Q20/3 |
LoseBRTX / S&P -54.04% / 4.30% |
LoseBRTX / S&P 4.55% / 6.64% |
LoseBRTX / S&P BRTX unavailable / 8.65% |
| 2019-Q11/3 |
LoseBRTX / S&P -12.22% / 13.65% |
WinBRTX / S&P 30.11% / 8.12% |
LoseBRTX / S&P BRTX unavailable / 14.29% |
| 2018-Q41/3 |
LoseBRTX / S&P -48.57% / -13.52% |
WinBRTX / S&P 37.04% / 9.05% |
LoseBRTX / S&P BRTX unavailable / 18.23% |
| 2018-Q31/3 |
LoseBRTX / S&P -6.42% / 7.71% |
WinBRTX / S&P 144.52% / 10.21% |
LoseBRTX / S&P BRTX unavailable / 19.06% |
| 2018-Q21/3 |
LoseBRTX / S&P -41.19% / 3.43% |
WinBRTX / S&P 188.90% / 9.03% |
LoseBRTX / S&P BRTX unavailable / 14.46% |
| 2018-Q11/3 |
LoseBRTX / S&P -14.05% / -0.76% |
WinBRTX / S&P 171.69% / 7.68% |
LoseBRTX / S&P BRTX unavailable / 12.46% |
| 2017-Q42/3 |
WinBRTX / S&P 13.85% / 6.64% |
WinBRTX / S&P 122.80% / 7.03% |
LoseBRTX / S&P BRTX unavailable / 13.82% |
| 2017-Q31/3 |
WinBRTX / S&P 8.33% / 4.48% |
LoseBRTX / S&P -78.61% / 5.68% |
LoseBRTX / S&P BRTX unavailable / 17.57% |
| 2017-Q20/3 |
LoseBRTX / S&P -29.41% / 3.09% |
LoseBRTX / S&P -88.12% / 4.83% |
LoseBRTX / S&P BRTX unavailable / 17.74% |
| 2017-Q11/3 |
WinBRTX / S&P 28.79% / 6.07% |
LoseBRTX / S&P -92.45% / 3.67% |
LoseBRTX / S&P BRTX unavailable / 13.32% |
| 2016-Q40/3 |
LoseBRTX / S&P 0.00% / 3.82% |
LoseBRTX / S&P -94.22% / 2.09% |
LoseBRTX / S&P BRTX unavailable / 7.05% |
| 2016-Q30/3 |
LoseBRTX / S&P -10.81% / 3.85% |
LoseBRTX / S&P -54.98% / 0.20% |
LoseBRTX / S&P BRTX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | BRTX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -88.80% | 20.78% |
| Annualized return | -88.80% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | BRTX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -98.39% | 83.14% |
| Annualized return | -56.21% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | BRTX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -67.00% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |